Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-10

Clinical Trial Update: Study to Determine the Efficacy of Real-time CGM in Preventing Hypoglycemia Among Insulin-treated Patients With DM2 on Hemodialysis, Compared to Standard of Care (POC BG) [NA]

View source ↗

Summary

A completed clinical trial compared real-time continuous glucose monitoring to standard care for preventing hypoglycemia in insulin-treated patients with type 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Emory University | Conditions: End-Stage Renal Disease, Type 2 Diabetes | NA | Status: COMPLETED | Results posted: 2025-02-10